Gastroenterology News

Among patients with Barrett’s esophagus, every 5 kg/m2 increase in BMI was associated with up to a 6% relative increase in the risk for malignant progression, according to a systematic review and meta-analysis.

Use of glucagon-like peptide-1 receptor agonists was associated with a reduced risk for progression to cirrhosis and other complications in patients with metabolic dysfunction-associated steatotic liver disease and diabetes, data showed.

The 2024 election is one of the most consequential elections in recent history, and as physicians, we have a responsibility to vote.

Early endoscopic improvement after Skyrizi induction was associated with fewer Crohn’s disease-related hospitalizations and surgeries through 52 weeks of maintenance in patients with moderately to severely active disease, research showed.

Most physicians and residents report feelings of burnout, while stigma about receiving mental health care remains prevalent, according to a new report from The Physicians Foundation.

Several notable guideline updates have been made in gastroenterology and hepatology for the diagnosis, management and treatment of GI and liver disorders. Wondering what you may have missed?

Most recipients of early liver transplant for severe alcohol-related liver disease live in close proximity to transplant centers, which are more likely to be in socially advantaged areas, according to research in Gastro Hep Advances.

In a Healio video exclusive, Edward V. Loftus Jr., MD, noted that the booming popularity in glucagon-like peptide-1 agonists have spurred an interspecialty “dilemma” regarding aspiration risks in the endoscopy suite.

The use of glucagon-like peptide-1 receptor agonists exponentially increased in recent years for treating diabetes and obesity, with benefits also observed in other cardiometabolic syndromes.